The End-to-End Solution

A CDMO at the heart of the client’s needs

The development of ATMP is a long and rigorous process that requires transversal knowledge and daily support. The heterogeneity of cell therapy products necessarily requires agility from your CDMO partner.

 

This is why our highly skilled teams are focused and mobilized to provide phased and adapted solutions to the clients’ needs.

PROCESS

ANALYTICS

REGULATORY

No compromise between QUANTITY and QUALITY !

A perfect continuum of services adapted to each stage of your project

As a leading One-Stop-ATMP-Shop provider, we are committed to meet your specific needs while respecting the regulatory framework in force.

Our teams have a perfect understanding of the complex journey of ATMP development and can quickly identify bottlenecks in each development steps :

 

  • Tissue & Cell Sourcing
  • Analytics
  • Process Development
  • Regulatory Support
  • Analytical Development
  • Fill & Finish
  • cGMP Manufacturing

Process Development

Analytical Development

cGMP Manufacturing

Analytics

Regulatory Support

Clinical grade Tissue & Cell sourcing

Clinical grade Tissue and Cell Sourcing

Through a strong partnership with Hospital/Clinic network, we propose a wide range of Good Manufacturing Practices (GMP) grade materials to facilitate your clinical Development.

 

      • Cell/Tissue from healthy Donors
      • Various Cell Lines
      • Cells from patients cohort through local clinicians network

Process Development

From UpStream to DownStream Process Development, we provide tailored solutions to bring robustness, cost-control and time-saving to your process.

 

      • Optimization of process parameters
      • From 1mL to >50L
      • Strong experience in cell process technologies (isolation, Harvesting, Washing, Filtration, Concentration, Formulation, Cryoconservation…)

Analytical Development

Our Quality by Design (QbD) approach defines the framework for cell product production. We pay close attention to the product specification parameters in order to better characterize the manufacturing process and the quality of the final product while respecting regulatory compliance.

 

    • Custom-made potency assay
    • Definition of Critical Quality Attributes (CQA)
    • Safety, Identity and therapeutic performance

Have a project you would like to share?

Contact Us

Good Manufacturing Practices (GMP) Manufacturing

Our experienced Team is working daily in a new state-of-the-art facility authorized by the National Agency for the Safety of Medicines and Health Products (ANSM). We provide services from Technology Transfer to Clinical manufacturing with fully equipped R&D labs, QC labs and Grade-B cleanroom suites to advance ATMPs from lab to market.

 

    • 3 Grade B cleanroom suites fully equipped
    • Dedicated QC labs
    • Fully qualified equipments

 

Analytics

Cell-Easy has strong experience in developing Analytical methods for ATMPs. We perform method development, including GMP-compliant method validation and stability studies

Our highly skilled Analytical Development team as well as our well-established GMP certified partners enables our customers to access high value-added services for Product development success.

Make the right Analytics decision in a reduced time with our Cellanalytics platform

 

    • Identity
    • Safety
    • Efficacy

Fill & Finish

From allogeneic to autologous products, we are able to adapt and propose the best solution to meet your specific need.

We offer complete Fill & Finish Services for liquid-formulated drug products :

 

    • Aseptic filling
    • Packaging
    • QC tests
    • Storage
    • Labeling
    • Shipping
Regulatory Support

The Quality by Design approach used at Cell-Easy corresponds to the requirements of the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) in the submission of Investigational Medicinal Product Dossier (IMPD) or Investigational New Drug (IND) application.

Our qualified Quality Assurance (QA) team supported by a robust Quality Management System (QMS), has all the necessary procedures in place for Cell Bank and Drug Substance batch release and for Drug Product batch certification for use in clinical trials. Our QMS combined to stringent QC procedures allows for complete control and traceability of your ATMP manufacturing process.

 

    • Documentation management
    • Deviations, change control, CAPA
    • Material and provider qualifications
    • Regulatory agencies facilitator
    • Audits
Clinical ATMP value chain

YOU are a Scientist, a Clinician, a Drug developer company…

YOU make part of the outstanding Advanced Cell & Gene Therapy success value chain !

Whoever you are, Cell-Easy is the perfect CDMO committed to support you in your success and to be the missing link between each of you. 

Our fast-growing network will be your next key success factor.

Have a project you would like to share?

Contact Us

Contact

  • Tel : +33 534 276 550
  • Address : Cell-Easy SAS, 4 bis avenue Hubert Curien, 31100 Toulouse, France
  • Mail : info@cell-easy.com
European leading CDMO company specialized in large volume industrialized production of GMP approved cell products